SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts Oct 31, 2022 09:25AM
SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts Oct 31, 2022 09:25AM
SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities Oct 28, 2022 01:20PM
LMF Acquisition Opportunities Inc (LMAO) Stockholders Approve Merger with SeasStar Medical Oct 19, 2022 05:52AM
LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc. Oct 18, 2022 06:00PM


Sep 28, 2022 05:00PM LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination
Sep 19, 2022 08:30AM SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development
Sep 19, 2022 08:30AM SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development
Aug 1, 2022 08:00AM SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD
Aug 1, 2022 08:00AM SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD
Aug 1, 2022 05:55AM LMF Acquisition Opportunities Inc (LMAO) Extends Deadline to Complete Business Combination
Jul 29, 2022 06:00PM LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination
Jul 29, 2022 06:00PM LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination
Jul 20, 2022 08:04AM SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury (LMAO)
Jul 20, 2022 08:00AM SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury
Jul 20, 2022 08:00AM SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury
Jun 7, 2022 08:30AM SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stoppin
Jun 7, 2022 08:30AM SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stoppin
May 24, 2022 08:03AM LMF Acquisition Opportunities Inc (LMAO) and SeaStar Medical Announce Appointment of Kevin Chung as Chief Medical Officer
May 24, 2022 08:00AM SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer
May 24, 2022 08:00AM SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer
May 3, 2022 08:01AM LMF Acquisition Opportunities Inc (LMAO) and SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
May 3, 2022 08:00AM SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
May 3, 2022 08:00AM SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
Apr 22, 2022 09:00AM SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities (LMAO)
Apr 22, 2022 09:00AM SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities, Inc.